Jean-laurent L. Deville
Marseille, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 01, 2025
A French Multicenter Real-Life Study on the Biological and Clinical Parameters Associated With Response to Immune Checkpoint Inhibitors (ICIs) in Second-Line Treatment of Advanced Urothelial Carcinoma: Impact of Antibiotics Administration at the Time of ICIs Initiation.
Journal: Clinical genitourinary cancer
Published: March 23, 2024
Derazantinib alone and with atezolizumab in metastatic urothelial carcinoma with activating FGFR aberrations.
Journal: JNCI cancer spectrum
Published: November 27, 2023
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma.
Journal: Journal for immunotherapy of cancer
Published: March 31, 2023
Urachal carcinoma: a large retrospective multicentric study from the French Genito-Urinary Tumor Group.
Journal: Frontiers in oncology
Published: November 28, 2022
Prognostic Value of the B12/CRP Index in Older Systemically Treatable Cancer Patients.
Journal: Cancers
Published: November 23, 2021
Adaptive dosing of sunitinib in a metastatic renal cell carcinoma patient: when in silico modeling helps to go quicker to the point.
Journal: Cancer chemotherapy and pharmacology
Published: October 11, 2021
TAXOMET: A French Prospective Multicentric Randomized Phase II Study of Docetaxel Plus Metformin Versus Docetaxel Plus Placebo in Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical genitourinary cancer
Published: June 15, 2021
Stereotactic Body Radiotherapy for Frail Patients with Primary Renal Cell Carcinoma: Preliminary Results after 4 Years of Experience.
Journal: Cancers
Published: May 26, 2021
Clinical-Based vs. Model-Based Adaptive Dosing Strategy: Retrospective Comparison in Real-World mRCC Patients Treated with Sunitinib.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 05, 2021
Erratum to 'Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database' [European Journal of Cancer, Volume 125 (January 2020) Pages 153-163].
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 30, 2020
Last Updated: 09/26/2026